Innate Therapeutics Receives Funding for Clinical Trial of Progressive ... - Businesswire.com

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service40 times read : Adjust font size: Decrease font Enlarge font
image

National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany. The award of funds will help support the conduct of a Phase 2A clinical trial in patients with progressive forms of MS using MIS416, a naturally ...

Read this article...



Post your comment comment Comments (0 posted)

copyright